Home
/ F2G
/ Competitors

F2G competitors and similar companiesClear all

F2G's competitors and similar companies include Joincare, Sandoz and Sumitomo Pharma.

	F2G F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.	Joincare Joincare (健康元药业集团股份有限公司) is a company that manufactures and supplies pharmaceuticals products.	Sandoz Sandoz is a company operating in generic and biosimilar medicines.	Sumitomo Pharma Sumitomo Pharma (住友ファーマ株式会社) is a company that manufactures and sells pharmaceuticals, food additives, and veterinary medicines.
Founding Date	Founding Date 1998	Founding Date 1992	Founding Date 1886	Founding Date 1897
Type	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma
Locations	Locations Eccles, GB HQ	Locations Shen Zhen, CN HQ	Locations Holzkirchen, DE HQ Basel, CH Broomfield, US East Hanover, US Princeton, US	Locations Tokyo, JP HQ Jiangsu, CN Shanghai, CN Fukuoka, JP Hiroshima, JP Hokkaido, JP Hyogo, JP see more
Employees	Employees 761% decrease	Employees 13,234	Employees 14,270	Employees 6,987
Valuation ($)	Valuation ($) N/A	Valuation ($) 3.4 b	Valuation ($) N/A	Valuation ($) 2.7 b
Alexa Website Rank	Alexa Website Rank N/A	Alexa Website Rank N/A	Alexa Website Rank 510745	Alexa Website Rank 396951
Employee Rating	Employee Rating 4	Employee Rating N/A	Employee Rating 4.1	Employee Rating N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥15.6b (FY, 2021)	Revenue (est.) N/A	Revenue (est.) ¥560b (FY, 2022)
Cost of goods	Cost of goods £9.5m (FY, 2018)	Cost of goods ¥5.7b (FY, 2021)	Cost of goods N/A	Cost of goods ¥150.5b (FY, 2022)
Gross profit	Gross profit N/A	Gross profit ¥10b (FY, 2021)	Gross profit N/A	Gross profit ¥411.7b (FY, 2022)
Net income	Net income £4.4m (FY, 2018)	Net income ¥2.6b (FY, 2021)	Net income N/A	Net income ¥40.6b (FY, 2022)